Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology

This bill requires health insurance plans to cover at least one abuse-deterrent opioid painkiller for each active ingredient, ensuring patients can access these FDA-approved options without higher out-of-pocket costs. It prohibits insurers from forcing patients to try non-abuse-deterrent opioids first for prior authorization or coverage approval. The law mandates that cost-sharing (like copays) for abuse-deterrent opioids must match the lowest level applied to non-abuse-deterrent versions. It directly affects patients prescribed opioid painkillers and insurance plans, aiming to improve access to formulations designed to reduce misuse.